Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 12(1): 15012, 2022 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-36056136

RESUMO

Several factors including sex and lifestyle have been reported to contribute to the age-related alteration of immune functions. The study was undertaken to determine age-related differences in the proportion of peripheral blood mononuclear lymphocytes in the Indian population using blood samples from 67 healthy adults (33 females and 34 males) aged between 20 and 80 years old. In the linear regression analysis to estimate the relationship with age categories, there was a significant increase in the frequency of natural killer cells with ageing, while their cytolytic activity significantly declined. The frequency of CD4+ T cells increased with age, whereas that of CD8+ T cells decreased, resulting in the age-associated increase of the CD4/CD8 ratio. The subsets of B cells did not show any significant relationship with age. Although there were variations between the male and female subgroups in effect size of ageing, the trends were in the same direction in all the parameters. Reduced fat intake was associated with a lower frequency of CD4+ T cells, and higher serum cotinine level was associated with a higher CD4/CD8 ratio. The results indicate that cellular immunity in the Indian population is affected by ageing, while humoral immunity is less susceptible to ageing.


Assuntos
Linfócitos T CD8-Positivos , Leucócitos Mononucleares , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento , Feminino , Citometria de Fluxo , Humanos , Estilo de Vida , Masculino , Pessoa de Meia-Idade , Adulto Jovem
2.
Proc Biol Sci ; 282(1821): 20152292, 2015 12 22.
Artigo em Inglês | MEDLINE | ID: mdl-26674951

RESUMO

Many populations live in environments subject to frequent biotic and abiotic changes. Nonetheless, it is interesting to ask whether an evolving population's mean fitness can increase indefinitely, and potentially without any limit, even in a constant environment. A recent study showed that fitness trajectories of Escherichia coli populations over 50 000 generations were better described by a power-law model than by a hyperbolic model. According to the power-law model, the rate of fitness gain declines over time but fitness has no upper limit, whereas the hyperbolic model implies a hard limit. Here, we examine whether the previously estimated power-law model predicts the fitness trajectory for an additional 10 000 generations. To that end, we conducted more than 1100 new competitive fitness assays. Consistent with the previous study, the power-law model fits the new data better than the hyperbolic model. We also analysed the variability in fitness among populations, finding subtle, but significant, heterogeneity in mean fitness. Some, but not all, of this variation reflects differences in mutation rate that evolved over time. Taken together, our results imply that both adaptation and divergence can continue indefinitely--or at least for a long time--even in a constant environment.


Assuntos
Escherichia coli/genética , Aptidão Genética , Adaptação Fisiológica/genética , Evolução Biológica , Meio Ambiente , Genética Populacional , Modelos Genéticos , Taxa de Mutação
3.
Indian J Gastroenterol ; 34(2): 93-107, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25917520

RESUMO

New insights from a rapidly developing field of research have ushered in a new era of understanding of the complexity of host-microbe interactions within the human body. The paradigm shift from culturing to metagenomics has provided an insight into the complex diversity of the microbial species that we harbor, revealing the fact that we are in fact more microbes than human cells. The largest consortium of these microbes resides in the gut and is called the gut microbiota. This new science has expanded the ability to document shifts in microbial populations to an unparalleled degree. It is now understood that signals from the microbiota provide trophic, nutritional, metabolic, and protective effects for the development and maintenance of the host digestive, immune, and neuroendocrine system. Evidence linking changes in the gut microbiota to gastrointestinal and extraintestinal disorders like irritable bowel syndrome, inflammatory bowel disease, obesity, diabetes, and celiac disease have begun to emerge recently. Probiotics act through diverse mechanisms positively affecting the composition and/or function of the commensal microbiota and alter host immunological responses. Well-controlled intervention trials, systematic reviews, and meta-analysis provide convincing evidence for the benefit of probiotics in prevention and treatment of gastrointestinal as well as extraintestinal disorders.


Assuntos
Microbioma Gastrointestinal , Probióticos/uso terapêutico , Doenças do Sistema Digestório/etiologia , Doenças do Sistema Digestório/prevenção & controle , Doenças do Sistema Digestório/terapia , Doenças do Sistema Endócrino/etiologia , Doenças do Sistema Endócrino/prevenção & controle , Doenças do Sistema Endócrino/terapia , Transplante de Microbiota Fecal , Microbioma Gastrointestinal/fisiologia , Humanos , Doenças do Sistema Imunitário/etiologia , Doenças do Sistema Imunitário/prevenção & controle , Doenças do Sistema Imunitário/terapia , Doenças Metabólicas/etiologia , Doenças Metabólicas/prevenção & controle , Doenças Metabólicas/terapia , Metagenômica , Doenças do Sistema Nervoso/etiologia , Doenças do Sistema Nervoso/prevenção & controle , Doenças do Sistema Nervoso/terapia
4.
Indian J Med Res ; 139(1): 19-26, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24604038

RESUMO

Probiotics are defined as live microorganisms which, when ingested in adequate amounts, confer health benefits on the host. Chronic diseases such as diabetes, non-alcoholic fatty liver disease, coronary artery disease, a variety of chronic inflammatory disorders with an immune basis, and some forms of cancer are increasing in incidence around the world and in India, and may be attributable in part to rapid changes in our lifestyle. There is considerable public interest in India in the consumption of probiotic foods. This brief review summarizes the background of the gut microbiota, the immunological reactions induced by these, the evidence linking the microbiota to health outcomes, and the evidence linking the use of probiotics for amelioration of chronic lifestyle diseases.


Assuntos
Bifidobacterium/metabolismo , Doença Crônica/prevenção & controle , Trato Gastrointestinal/efeitos dos fármacos , Probióticos/uso terapêutico , Doença Crônica/epidemiologia , Efeitos Psicossociais da Doença , Alimentos , Trato Gastrointestinal/microbiologia , Humanos , Índia , Estilo de Vida , Microbiota/efeitos dos fármacos
5.
Gut Pathog ; 4(1): 1, 2012 Mar 12.
Artigo em Inglês | MEDLINE | ID: mdl-22410274

RESUMO

Our understanding of the role of the microbiota in our gut and other sites in our body is rapidly emerging and could lead to many new and innovative approaches for health care. The promise of the potential role of probiotics for the prevention and treatment of enteric and other infections as an effective solution needs to be realized. The meeting report summarizes the insights and learning from a recent symposium, "Health Impact of Probiotics - Vision and Opportunities" conducted in Mumbai by the Yakult India Microbiota and Probiotic Science Foundation and P.D. Hinduja National Hospital, Mumbai. The symposium reflected its objective of unraveling the potential role of probiotics for health benefits through presentations and discussions. Experts clearly highlighted the role of probiotics in improving various aspects of health and in immune modulation. The report also captures the debate and discussions on the challenges that are likely to be encountered for the use of probiotics in the country.

6.
Gut Pathog ; 2(1): 10, 2010 Aug 29.
Artigo em Inglês | MEDLINE | ID: mdl-20799986

RESUMO

With more than 1.4 million of the 9 million child deaths being attributed to diarrhoea in 2008 and 49% of them occurring in five countries namely, India, Nigeria, Democratic Republic of the Congo, Pakistan and China, there is an urgent need for intervention to prevent and control diarrhoeal diseases. Of the various interventions, probiotics offer immense potential. The past decade has witnessed the validation of their utility for the prevention, treatment and management of a variety of infective and non infective disorders. The most investigated field continues to remain infectious diarrhoea and compelling evidence comes from randomized placebo controlled trials. While results from these studies are encouraging most of them reflect the outcomes of the developed world. Developing countries like India continue to struggle with nutritional and health challenges and bear the greatest burden of diarrhoea. A paucity of data from the developing countries limits the definite recommendation of probiotics. In these countries curd, often confused for a probiotic, is practiced as an integral part of the culture. While the nutritional benefits of these products cannot be understated, it is still uncertain whether these products can be classified as a probiotic. The emergence of probiotic foods which are scientifically validated for their efficacy and impart defined health benefits offer an excellent opportunity to improve public health. A recent randomized controlled trial conducted by the National Institute of Cholera and Enteric Diseases in Kolkata, India demonstrated a protective efficacy of 14% in preventing diarrhoea among children who received a probiotic. For the developing world however the vision for probiotics would mean a fundamental change in perception and developing a well planned strategy to allow interventions like probiotics to permeate to impoverished settings, where the assault of micro organisms is on a daily basis. This would mean that probiotics are ingrained into the public health system without being seen as a medicine.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...